Measles Cases Surge in the US, Raising Concerns Over elimination Status
Table of Contents
The United States is facing a important resurgence of measles, with case numbers reaching levels not seen in decades, prompting renewed calls for vigilance among healthcare providers and a focus on vaccination efforts.
The Centers for Disease Control and Prevention (CDC) has confirmed 1,563 measles cases across the U.S. as of October 7, 2025 – a figure exceeding the 1,274 cases reported in 2019 and the highest since 1992, when 2,126 cases were recorded. This alarming trend signals a potential loss of the nation’s “elimination status,” achieved in 2000, meaning ongoing endemic or local transmission is no longer present.
“We are perhaps at risk of losing elimination status,” stated Michael J. Bozzella, DO, MS, during his presentation, titled “Measles: A facepalm heard around the world,” at the OMED conference in Nashville.
The rise in cases is largely attributed to declining immunization levels fueled by increasing anti-vaccine sentiment. A recent outbreak in Tennessee, for instance, saw all six children affected unvaccinated against the disease. “We still have some pretty staggering numbers to deal with,” Bozzella emp
For Accurate Diagnosis
When evaluating a patient suspected of having measles,physicians should focus on specific historical and clinical indicators. A classic teaching, Bozzella noted, is to consider measles in the differential diagnosis whenever a complex rash is observed, but cautioned that this alone is not definitive.
Crucial “red flags” include the presence of a rash after the onset of fever, accompanied by cough, coryza, and conjunctivitis – the hallmark “three Cs” associated with measles. equally critically important is the timing and progression of the rash.
“Did this rash come after fever or those other symptoms, and did the rash start up here and then move down the body?” Bozzella asked rhetorically. “Those are really going to be those key things to hone in on – ‘Yup, this sounds like a classic or a clinical presentation of measles.'”
Beyond clinical presentation, a thorough assessment of epidemiological risk factors is essential. This includes recent travel history – both international and domestic to known outbreak areas – vaccination status, and the immunization status of close contacts. “It’s really going to be about the epidemiological risk factors,” Bozzella said. “Basically, where has this person been? Have they been around anybody who’s been diagnosed or suspected to have measles?”
Leveraging Technology and Resources
Recognizing the complexity of diagnosis, healthcare professionals can utilize several resources to aid in their assessment.Bozzella highlighted the Firstline app – a collaboration between Children’s Hospital Colorado, Denver Health, and a stewardship group – as a valuable tool. The app provides extensive facts on various pathogens, antimicrobial dosing, and clinical pathways, including specific guidance for measles.
The app features a decision-support tool to help clinicians determine the level of concern for measles in individual cases, guiding them on whether to monitor, test, or consult with specialists. Additionally, resources from the American Academy of Pediatrics (AAP), the CDC, and other medical organizations are readily available. The AAP’s Red Book online, such as, addresses specific questions, such as adjusting vaccination schedules during outbreaks. Healio also offers a dedicated measles clinical guidance module.
Ultimately, accurate diagnosis requires a meticulous approach, combining clinical acumen with a thorough understanding of epidemiological factors and the utilization of available resources. The current surge in measles cases underscores the critical importance of these efforts to protect public health and prevent a return to a pre-elimination era.
Source: Bozzella MJ. Measles: A facepalm heard around the world. Presented at OMED; Sept.25-28, 2025; Nashville.
Disclosures: Bozzella reports no relevant financial disclosures.
